Silo Pharma Inc.
SILO | NASDAQ
$1.23
-$0.02 (-1.60%)
At close: Oct 30, 2026, 4:00 PM ET
$1.23
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 7:55 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.68 | -0.75 | -1.20 | -1.96 | 5.42 | -7.45 |
PEG Ratio | 0.01 | 0.90 | 0.04 | 0.01 | -0.03 | -0.08 |
PS Ratio | 39.53 | 45.43 | 61.51 | 106.45 | 190.36 | n/a |
PB Ratio | 0.45 | 0.65 | 0.72 | 0.74 | 1.50 | 18.02 |
P/FCF Ratio | -0.61 | -0.85 | -1.38 | -2.19 | -5.96 | -19.95 |
P/OCF Ratio | -0.61 | -0.85 | -1.38 | -2.19 | -5.96 | -19.95 |
OCF/S Ratio | -6.46K | -5.32K | -4.47K | -4.85K | -3.2K | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | 0.01 |
Quick Ratio | 11.36 | 4.29 | 9.90 | 26.52 | 21.23 | 9.83 |
Current Ratio | 11.36 | 4.29 | 9.90 | 26.52 | 21.23 | 10.07 |
Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | n/a |
Interest Coverage | -114.76 | -925.59 | -791.87 | -1.65K | -903.93 | -8.18 |
Return on Equity | -67.05% | -87.26% | -59.91% | -37.80% | 43.08% | -237.18% |
Return on Assets | -55.59% | -59.27% | -47.77% | -33.57% | 37.21% | -212.91% |
Return on Invested Capital | -61.55% | -81.76% | -55.31% | -32.37% | -27.28% | -169.42% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -1.13K% | 91.90% | 91.90% | 91.90% | 92.98% | n/a |
Net Profit Margin | -5.86K% | -6.09K% | -5.13K% | -5.42K% | 5.48K% | n/a |
Pretax Profit Margin | -5.86K% | -6.09K% | -5.04K% | -5.42K% | 5.87K% | n/a |
Operating Profit Margin | -5.94K% | -6.53K% | -5.35K% | -5.03K% | -3.85K% | n/a |
FCF Margin | -6.46K% | -5.32K% | -4.47K% | -4.85K% | -3.2K% | n/a |
EBITDA Margin | -5.8K% | -6.08K% | -5.03K% | -5.42K% | 5.87K% | n/a |
Add to Watchlist
Select watchlists to add or remove SILO